To further understand the underlying molecular mechanism of Nob in the treatment and prevention of skeletal muscle atrophy, we examined the protein synthesis signaling pathways (mTOR/Akt) in the CK, D-gal, and D-gal + Nob groups. The gene discussed is AKT1; the disease is Skeletal muscle atrophy.